— Know what they know.
Not Investment Advice
Also trades as: GNS.L (LSE) · $vol 6M

GENSF OTC

Genus plc
1W: +1.5% 1M: -6.9% 3M: -6.9% YTD: -17.3% 1Y: -17.7% 3Y: -15.0% 5Y: -59.5%
$28.95
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 40 · $1.9B mcap · 65M float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$89M +32.5% ▲
5Y CAGR: +5.7%
Capital Expenditures
$12M +33.9% ▲
5Y CAGR: -15.6%
Free Cash Flow
$77M +57.9% ▲
5Y CAGR: +14.6%
Dividends Paid
$21M -1.2% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$6M -207.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2026
— Operating Activities —
Net Income$41M$32M$8M$19M$281M
Depreciation & Amort.$35M$44M$47M$45M$40M
Stock-Based Comp.$4M$6M$7M$7M$0
Change in Working Capital-$25M-$12M-$11M$11M-$11M
Other Non-Cash Items-$17M$21M-$21M-$15M-$215M
Operating Cash Flow$34M$50M$30M$67M$89M
— Investing Activities —
Capital Expenditures-$42M-$35M-$15M-$13M-$18M
Acquisitions (Net)-$16M-$2M-$3M$700K-$590K
Investment Purchases-$3M-$400K$0-$2M$0
Investment Sales$19M$3M$5M$0$96M
Other Investing-$25M$3M-$7M$1M$0
Investing Cash Flow-$67M-$31M-$19M-$14M$78M
— Financing Activities —
Net Debt Issuance$55M$4M$32M-$5M-$139M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$21M-$21M-$21M-$21M-$21M
Other Financing-$12M-$1M-$14M-$20M-$12M
Financing Cash Flow$22M-$18M-$3M-$47M-$172M
Net Change in Cash-$7M-$2M$6M$6M-$6M
Cash End of Period$39M$36M$42M$48M$43M
Free Cash Flow-$8M$15M$5M$49M$77M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms